Skip to main content

Solutions

Clinical solutions

Blended Solutions Cardiac Safety Solutions Clinical & Scientific Operations Decentralised Clinical Trials Early Clinical Laboratories Medical Imaging Site & Patient Solutions Strategic Solutions

Consulting & Commercial

Asset Development Consulting Commercial Positioning Language Services Outcome Measures Real World Intelligence Regulatory Affairs Symphony Health data

Case studies
Reducing time to market, delivering on quality, providing deep therapeutic expertise and enhancing R&D ROI.

Technologies
Technology solutions from early phase through to post-marketing.
Sectors

Sectors

ICON provides its full range of clinical, consulting and commercial services across several industry sectors.

Read more

Biotech Government and Public Health Medical Device Pharmaceuticals

Biotech
Developing transformative therapies requires a flexible approach.

ICON and You
Partners making a difference.
Therapeutics

Therapeutics

Cardiovascular Central Nervous System Endocrine & Metabolic Disorders Hepatology Infectious Diseases Internal Medicine & Immunology Oncology

Cross-therapeutics

Biosimilars Cell and Gene Therapies Medical Device Pediatrics Rare & Orphan Diseases Vaccines Women's Health

Obesity
A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment.

Therapeutics insights
ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.
Insights

Insights

Digital Disruption Patient Centricity Regulatory Intelligence Therapeutics insights Transforming Trials Value Based Healthcare Blog Videos Webinar Channel

Making sense of the rapidly changing biosimilars landscape
Strategies for adapting and achieving optimal market access

Building a comparative evidence base using network meta-analysis
Methods, implementation and reporting

From bottlenecks to breakthroughs
Human-centred strategies for faster study starts
News & Events

News & Events

ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.

Read more

Press releases In the News Mediakit Awards Events Webinars Social media

Panel discussion: Flow cytometry in bioanalysis
26 March 2026. Register today.

ICH GCP E6(R3): Preparing for global implementation, assessing the impact, risk and requirements of the change
Watch the webinar.
About ICON

About ICON

Company history ICON at a glance ICON in Asia Pacific ICON in Latin America Leadership Quality

ICON for

Patients Volunteers Investigators Jobs & Careers Investors Suppliers

Sustainability, charity, inclusion and belonging
ICON Cares is our commitment to making a positive impact on our people, environment and our community.

ICON at a glance
Delivering successful outcomes across the clinical development lifecycle.

Careers
Investors
Contact
日本語
简体中文

Home
News & Events
Social media

Social media

Showing 1033 - 1033 of 1033 results for "*"

ICON Plc

Multi-indication development is now central to cardiometabolic drug pipelines. A 2025 ICON survey shows 83% of developers engage in multi-indication therapies. What commercialisation strategies are they employing? Explor...

11 Aug

3

View post

View webpage

Previous
1
…
85
86
87

Filter by:

Topic

Social Channel

Site Branding

Contact
About ICON
Results & Reports

For Clients

Therapeutics
Solutions
Insights
Technologies
Content preferences
Office locations

ICON for

Patients
Volunteers
Investigators
Jobs & Careers
Investors
Suppliers

News & Events

Press releases
Mediakit
Events
Webinars

Socials

Linkedin
Facebook
Instagram
Youtube

Legal Footer

Disclaimer
Privacy & Data
Cookies

How can we help?

All
Website

Search for website content

Popular search terms:

Biotech
Cell and Gene Therapies
Consulting
Early Clinical
Medical Device
Oncology
Rare & Orphan Diseases
Real World Evidence
Site & Patient Recruitment
Strategic Solutions
Regulatory Intelligence

Social media

Page tools